Cargando…

Parkinson Disease Protein 7 (PARK7) Is Related to the Ability of Mammalian Sperm to Undergo In Vitro Capacitation

Parkinson disease protein 7 (PARK7) is a multifunctional protein known to be involved in the regulation of sperm motility, mitochondrial function, and oxidative stress response in mammalian sperm. While ROS generation is needed to activate the downstream signaling pathways required for sperm to unde...

Descripción completa

Detalles Bibliográficos
Autores principales: Recuero, Sandra, Delgado-Bermúdez, Ariadna, Mateo-Otero, Yentel, Garcia-Bonavila, Estela, Llavanera, Marc, Yeste, Marc
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8509420/
https://www.ncbi.nlm.nih.gov/pubmed/34639144
http://dx.doi.org/10.3390/ijms221910804
_version_ 1784582336148406272
author Recuero, Sandra
Delgado-Bermúdez, Ariadna
Mateo-Otero, Yentel
Garcia-Bonavila, Estela
Llavanera, Marc
Yeste, Marc
author_facet Recuero, Sandra
Delgado-Bermúdez, Ariadna
Mateo-Otero, Yentel
Garcia-Bonavila, Estela
Llavanera, Marc
Yeste, Marc
author_sort Recuero, Sandra
collection PubMed
description Parkinson disease protein 7 (PARK7) is a multifunctional protein known to be involved in the regulation of sperm motility, mitochondrial function, and oxidative stress response in mammalian sperm. While ROS generation is needed to activate the downstream signaling pathways required for sperm to undergo capacitation, oxidative stress has detrimental effects for sperm cells and a precise balance between ROS levels and antioxidant activity is needed. Considering the putative antioxidant role of PARK7, the present work sought to determine whether this protein is related to the sperm ability to withstand in vitro capacitation. To this end, and using the pig as a model, semen samples were incubated in capacitation medium for 300 min; the acrosomal exocytosis was triggered by the addition of progesterone after 240 min of incubation. At each relevant time point (0, 120, 240, 250, and 300 min), sperm motility, acrosome and plasma membrane integrity, membrane lipid disorder, mitochondrial membrane potential, intracellular calcium and ROS were evaluated. In addition, localization and protein levels of PARK7 were also assessed through immunofluorescence and immunoblotting. Based on the relative content of PARK7, two groups of samples were set. As early as 120 min of incubation, sperm samples with larger PARK7 content showed higher percentages of viable and acrosome-intact sperm, lipid disorder and superoxide levels, and lower intracellular calcium levels when compared to sperm samples with lower PARK7. These data suggest that PARK7 could play a role in preventing sperm from undergoing premature capacitation, maintaining sperm viability and providing a better ability to keep ROS homeostasis, which is needed to elicit sperm capacitation. Further studies are required to elucidate the antioxidant properties of PARK7 during in vitro capacitation and acrosomal exocytosis of mammalian sperm, and the relationship between PARK7 and sperm motility.
format Online
Article
Text
id pubmed-8509420
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-85094202021-10-13 Parkinson Disease Protein 7 (PARK7) Is Related to the Ability of Mammalian Sperm to Undergo In Vitro Capacitation Recuero, Sandra Delgado-Bermúdez, Ariadna Mateo-Otero, Yentel Garcia-Bonavila, Estela Llavanera, Marc Yeste, Marc Int J Mol Sci Article Parkinson disease protein 7 (PARK7) is a multifunctional protein known to be involved in the regulation of sperm motility, mitochondrial function, and oxidative stress response in mammalian sperm. While ROS generation is needed to activate the downstream signaling pathways required for sperm to undergo capacitation, oxidative stress has detrimental effects for sperm cells and a precise balance between ROS levels and antioxidant activity is needed. Considering the putative antioxidant role of PARK7, the present work sought to determine whether this protein is related to the sperm ability to withstand in vitro capacitation. To this end, and using the pig as a model, semen samples were incubated in capacitation medium for 300 min; the acrosomal exocytosis was triggered by the addition of progesterone after 240 min of incubation. At each relevant time point (0, 120, 240, 250, and 300 min), sperm motility, acrosome and plasma membrane integrity, membrane lipid disorder, mitochondrial membrane potential, intracellular calcium and ROS were evaluated. In addition, localization and protein levels of PARK7 were also assessed through immunofluorescence and immunoblotting. Based on the relative content of PARK7, two groups of samples were set. As early as 120 min of incubation, sperm samples with larger PARK7 content showed higher percentages of viable and acrosome-intact sperm, lipid disorder and superoxide levels, and lower intracellular calcium levels when compared to sperm samples with lower PARK7. These data suggest that PARK7 could play a role in preventing sperm from undergoing premature capacitation, maintaining sperm viability and providing a better ability to keep ROS homeostasis, which is needed to elicit sperm capacitation. Further studies are required to elucidate the antioxidant properties of PARK7 during in vitro capacitation and acrosomal exocytosis of mammalian sperm, and the relationship between PARK7 and sperm motility. MDPI 2021-10-06 /pmc/articles/PMC8509420/ /pubmed/34639144 http://dx.doi.org/10.3390/ijms221910804 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Recuero, Sandra
Delgado-Bermúdez, Ariadna
Mateo-Otero, Yentel
Garcia-Bonavila, Estela
Llavanera, Marc
Yeste, Marc
Parkinson Disease Protein 7 (PARK7) Is Related to the Ability of Mammalian Sperm to Undergo In Vitro Capacitation
title Parkinson Disease Protein 7 (PARK7) Is Related to the Ability of Mammalian Sperm to Undergo In Vitro Capacitation
title_full Parkinson Disease Protein 7 (PARK7) Is Related to the Ability of Mammalian Sperm to Undergo In Vitro Capacitation
title_fullStr Parkinson Disease Protein 7 (PARK7) Is Related to the Ability of Mammalian Sperm to Undergo In Vitro Capacitation
title_full_unstemmed Parkinson Disease Protein 7 (PARK7) Is Related to the Ability of Mammalian Sperm to Undergo In Vitro Capacitation
title_short Parkinson Disease Protein 7 (PARK7) Is Related to the Ability of Mammalian Sperm to Undergo In Vitro Capacitation
title_sort parkinson disease protein 7 (park7) is related to the ability of mammalian sperm to undergo in vitro capacitation
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8509420/
https://www.ncbi.nlm.nih.gov/pubmed/34639144
http://dx.doi.org/10.3390/ijms221910804
work_keys_str_mv AT recuerosandra parkinsondiseaseprotein7park7isrelatedtotheabilityofmammalianspermtoundergoinvitrocapacitation
AT delgadobermudezariadna parkinsondiseaseprotein7park7isrelatedtotheabilityofmammalianspermtoundergoinvitrocapacitation
AT mateooteroyentel parkinsondiseaseprotein7park7isrelatedtotheabilityofmammalianspermtoundergoinvitrocapacitation
AT garciabonavilaestela parkinsondiseaseprotein7park7isrelatedtotheabilityofmammalianspermtoundergoinvitrocapacitation
AT llavaneramarc parkinsondiseaseprotein7park7isrelatedtotheabilityofmammalianspermtoundergoinvitrocapacitation
AT yestemarc parkinsondiseaseprotein7park7isrelatedtotheabilityofmammalianspermtoundergoinvitrocapacitation